ChemicalBook > Product Catalog >API >Circulatory system drugs >Antihypertensive drugs >Irbesartan

Irbesartan

Irbesartan Structure
CAS No.
138402-11-6
Chemical Name:
Irbesartan
Synonyms
AVAPRO;Lrbesartan;Irbesatan;Irbesartan Impurity 1;3-butyl-2-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;APROVEL;CS-1097;SR-47436;Irbesarta;BMS-186295
CBNumber:
CB4454663
Molecular Formula:
C25H28N6O
Molecular Weight:
428.53
MOL File:
138402-11-6.mol
MSDS File:
SDS
Modify Date:
2024/7/24 17:31:20

Irbesartan Properties

Melting point 180-181°C
Boiling point 648.6±65.0 °C(Predicted)
Density 1.30±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: >25mg/mL
pka 4.16±0.10(Predicted)
form powder
color white to off-white
Merck 14,5083
BCS Class 2
CAS DataBase Reference 138402-11-6(CAS DataBase Reference)
EPA Substance Registry System 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (138402-11-6)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08,GHS09,GHS02
Signal word  Danger
Hazard statements  H413
Precautionary statements  P501-P273
Hazard Codes  Xn
Risk Statements  22
Safety Statements  26-24/25
WGK Germany  3
RTECS  HM2950270
HS Code  29332900
NFPA 704
0
2 0

Irbesartan price More Price(5)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) PHR1443 Irbesartan Pharmaceutical Secondary Standard; Certified Reference Material 138402-11-6 1G ₹9103.83 2022-06-14 Buy
Sigma-Aldrich(India) I2286 Irbesartan ≥98% (HPLC), powder 138402-11-6 10MG ₹9428.58 2022-06-14 Buy
Sigma-Aldrich(India) I2286 Irbesartan ≥98% (HPLC), powder 138402-11-6 50MG ₹38017.4 2022-06-14 Buy
TCI Chemicals (India) I0859 Irbesartan 138402-11-6 1G ₹5500 2022-05-26 Buy
TCI Chemicals (India) I0859 Irbesartan 138402-11-6 5G ₹6900 2022-05-26 Buy
Product number Packaging Price Buy
PHR1443 1G ₹9103.83 Buy
I2286 10MG ₹9428.58 Buy
I2286 50MG ₹38017.4 Buy
I0859 1G ₹5500 Buy
I0859 5G ₹6900 Buy

Irbesartan Chemical Properties,Uses,Production

Description

Avapro was launched in Germany, the UK and the US for hypertension. It can be prepared in six steps starting with cyclopentanone or in three steps from 1- aminocyclopentanecarboxylic acid ethyl ester and pentanimidic ethyl ester. Avapro is an angiotensin Ⅱ receptor antagonist that is non-competitive and selective for AT, subtypes and has no AT2 activity at postsynaptic receptors compared to presynatpic. It has no affinity for various non angiotensin Ⅱ receptor types in binding, no interaction with calcium channels or antiports, and no affinity for α1- and α2--adrenoreceptors, serotonergic receptors, muscarinic m1 and m2 or other receptors. It is as potent as saralasin but with no agonist activity and is 10 times more potent than DuP753 in rats. It is similar in efficacy to enalapril (in those with severe hypertension) and atenolol, while more effective than losartan for mild to moderate hypertension.

Chemical Properties

Crystalline Solid

Uses

For the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of conges

Definition

ChEBI: A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

General Description

Irbesartan, 2-butyl-3-[[29-(1H-tetrazol-5-yl)[1,19-biphenyl]-4-yl]methyl]1,3-diazaspiro[4,4]non-1en-4-one (Avapro), like losartan, possesses the acidic tetrazolesystem, which most likely plays a role, similar to the acidicgroups of angiotensin II, in binding to the angiotensin II receptor.In addition, the biphenyl system that serves to separatethe tetrazole from the aliphatic nitrogen is still present.A major difference in this agent is that it does not possessthe acidic side chain. Even so, irbesartan has good affinityfor the angiotensin II receptor because of hydrogen bondingwith the carbonyl moiety of the amide system. Also, thisparticular agent does not require metabolic activation ascandesartan does.

Global( 792)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
GLR Innovations +91 9891111994 New Delhi, India 4542 58 Inquiry
Cadila Pharmaceuticals Ltd +91-7069076657 +91-7069076657 Ahmedabad, India 54 58 Inquiry
ANWITA APIS +919000311012 Hyderabad, India 198 58 Inquiry
Dr. Reddy's Laboratories Ltd +91-4049002900 +91-4049002900 Hyderabad, India 165 58 Inquiry
Hetero Drugs Limited +91-4023704923 +91-4023704923 Telangana, India 296 58 Inquiry
Macleods Pharmaceuticals Limited +91-2266762800 +91-2266762800 Maharashtra, India 116 58 Inquiry
Divis Laboratories Ltd +91-4066966413 +91-4066966413 Hyderabad, India 34 58 Inquiry
CTX Lifesciences Pvt Ltd +91-2612399669 +91-7434851395 Gujarat, India 28 58 Inquiry
Sun Pharmaceutical Industries Ltd +91-2242244224 +91-2243244324 Maharashtra, India 108 58 Inquiry
Unichem Laboratories Ltd +91-2266888333 +91-2266888333 Maharashtra, India 62 58 Inquiry

Irbesartan Spectrum

2-BUTYL-3-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1,3-DIAZASPIRO[4.4]NON-1-EN-4-ONE IRBESARTAN BMS-186295 APROVEL 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 2-Isopropryl-4-methylthiazole 2-butyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 2-butyl-3-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one 2-Isopropryl-4-methylthiazole (Irbesartan) Irbesartan (200 mg) Irbesartan(Avapro) 2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}Methyl)-1,3-diazaspiro[4.4]non-1-en-4-one 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 3-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one Irbesartan Synonyms 3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 3-((2'-(2H-Tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 2N-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride IrbesartanC25H28N6O 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-[(2-CYANOBIPHENYL-4-YL)METHYL]-2-IMIDAZOLIN-5-ONE 2-Butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one, BMS-186295, SR-47436, Aprovel, Avapro IRBESARTAN/3-BYTY1-3-[P-(0-1H-TETRAZOL-5-Y1-PHENY1)BENZY1],3-DIAZOSPIRO[4,4]NON-1-EN-4-KETONE 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-[(2-CYANOBIPHENYL-4-YL)METHYL]-2-IMIDAZOLIN-5-ONE(IRBESARTAN) 2-buty1-3-[p-(0-1H-tetrazol-5-y1-pheny1)benzy1]1,3-diazospiro[4,4]non-1-en-4-ketone 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4- Irbersartan 2-BUTYL-3-[2''-(1H-TETRAZOL-5-YL)BIPHENYL-4-YLMETHYL]1,3-DIAZA-SPIRO[4.4]NON-1-EN-4-ONE 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4- Irbesarta 2-Butyl-3-[[2’-(1H-tetrazol-5-y1)[1,l'-biphenyl]-4-y1]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one SR-47436 CS-1097 AVAPRO; SR-47436; BMS-186295 ebeisaotan 2-butyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one Irbesartan (SR-47436 Irbesartan, 99%, a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist Irbesartan Control Irbesartan> Irbesartan CRS Irbesartan USP/EP/BP Irbesartan (1347700) 3-butyl-2-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one AVAPRO Irbesatan Lrbesartan Irbesartan Impurity 1 tert-Butyl peroxybenzoate 614-45-9 IRBESARTAN 50% GRANULES Irbesartan 2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3- diazaspiro[4.4]non-1-en-4-one Irbesartan Reference Standard 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 138402-11-6 C25H28N6O 42854 C25H28ON6